# FDA Inspection 1005663 - Compound Preferred LLC - March 01, 2017

Source: https://www.keypedia.com/records/fda_inspections/compound-preferred-llc/c23faefa-7f51-4fa6-bb0f-e203e02d6580
Source feed: FDA_Inspections

> FDA Inspection 1005663 for Compound Preferred LLC on March 01, 2017. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1005663
- Company Name: Compound Preferred LLC
- Inspection Date: 2017-03-01
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1159061 - 2021-12-17](https://www.keypedia.com/records/fda_inspections/compound-preferred-llc/f75dd550-8079-42cf-8722-8f6bebb8f4ba)

Company: https://www.keypedia.com/companies/compound-preferred-llc/0137c1b7-e3ba-45ff-9fda-c53b21b0b857

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c